#diabetes
Latest news and interesting information about diabetes.
FDA OKs Inhaled Insulin for Kids
FDA approved MannKind's inhaled insulin Afrezza for children aged 6+ with diabetes. Needle-free option offers new hope for young patients.
Mizuho Starts Century Therapeutics at Outperform
Mizuho initiated coverage on Century Therapeutics with an Outperform rating and $8.00 target, highlighting cell therapy for Type 1 Diabetes.
Dexcom SWOT Analysis: Stock Faces Competitive Headwinds in 2026
Dexcom SWOT analysis for 2026: competitive challenges, margin pressures, and growth prospects in diabetes technology.
Simple way to reduce diabetes risk in 3 months
Simple way to reduce diabetes risk in 3 months revealed. Quit sugary drinks and adopt healthy eating habits to lower diabetes risk.
Bernstein Initiates Neurocrine with Outperform Rating
Bernstein initiates Neurocrine Biosciences with an outperform rating and $221 price target. Highlights Crenessity's potential and stock upside.
Over 10 Hydroelectric Plants Commissioned in Kalbajar
More than 10 hydroelectric plants commissioned in Kalbajar. Detailed information on energy supply and Istisu mineral water plant.
Arecor Grants 455,000 Stock Options
Arecor Therapeutics grants 455,000 stock options to executives under Long Term Incentive Plan. Details on vesting, performance conditions.
Retatrutide Shows 28.3% Weight Loss
Eli Lilly's retatrutide achieves 28.3% weight loss in Phase 3 TRIUMPH-1 trial. New hope for obesity treatment.
Strawberry: best summer berry for heart health
Spanish cardiologist Aurelio Roxas reveals that strawberries are the best summer berry for heart health, thanks to antioxidants and fiber.
William Blair Starts Insulet at Outperform
William Blair initiates Insulet at Outperform. Stock trades at 24x EPS, undervalued per Bond.az. Key concerns and catalysts detailed.
Jefferies Initiates SAB Biotherapeutics with Buy
Jefferies initiates coverage on SAB Biotherapeutics with a Buy rating and $11 target, focusing on SAB-142 diabetes therapy.
TrumpRx adds 600 generics to drug list
TrumpRx.gov adds over 600 generic drugs, including atorvastatin and metformin, to lower prescription costs.
...